Jci_page_head_homepage_01 Jci_page_head_homepage_02
Michael W. Rajala, Silvana Obici, Philipp E. Scherer, Luciano Rossetti
Published in Volume 111, Issue 2
J Clin Invest. 2003; 111(2):225–230 doi:10.1172/JCI16521
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

Effect of resistin and RELMβ during pancreatic clamp studies. The measurements were obtained while plasma glucose concentration was maintained at approximately 8.5 mM under steady-state conditions. (a) Rates of insulin infusion (IIR; mU/kg/min) required to maintain the plasma glucose concentrations at basal levels. (b) Effect of resistin and RELMβ on the rate of glucose production (GP; mg/kg/min). (c) Effect of resistin and RELMβ on hepatic insulin sensitivity (HIS). To take into account the differences in circulating plasma insulin levels during the pancreatic clamp studies, an index of HIS was calculated as GP–1/insulin (μU/ml) × 100. (d) Effect of resistin and RELMβ on peripheral insulin sensitivity (PIS). To take into account the differences in circulating plasma insulin levels during the pancreatic clamp studies, an index of peripheral insulin sensitivity was calculated as Rd (mg/kg/min)/insulin (μU/ml). Rd, rate of glucose disappearance. *P < 0.05 vs. vehicle.